James Barry - May 1, 2024 Form 3 Insider Report for BIO-RAD LABORATORIES, INC. (BIO BIOB)

Role
EVP, President, LSG
Signature
/s/ James Barry
Stock symbol
BIO BIOB
Transactions as of
May 1, 2024
Transactions value $
$0
Form type
3
Date filed
5/8/2024, 02:25 PM
Next filing
Sep 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BIO BIOB Bio-Rad A Common Stock 30.9 May 1, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BIO BIOB Restricted Stock Units May 1, 2024 Bio-Rad A Common Stock 217 $0.00 Direct F1, F6
holding BIO BIOB Restricted Stock Units May 1, 2024 Bio-Rad A Common Stock 265 $0.00 Direct F2, F6
holding BIO BIOB Restricted Stock Units May 1, 2024 Bio-Rad A Common Stock 355 $0.00 Direct F3, F6
holding BIO BIOB Restricted Stock Units May 1, 2024 Bio-Rad A Common Stock 521 $0.00 Direct F4, F6
holding BIO BIOB Restricted Stock Units May 1, 2024 Bio-Rad A Common Stock 1K $0.00 Direct F5, F6
holding BIO BIOB Non-Qualified Stock Option (right to buy) May 1, 2024 Bio-Rad A Common Stock 1.18K $343.76 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 3, 2019, the reporting person was granted 1,083 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.
F2 On September 2, 2020, the reporting person was granted 1,059 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F3 On September 1, 2021, the reporting person was granted 709 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F4 On September 1, 2022, the reporting person was granted 694 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F5 On September 1, 2023, the reporting person was granted 1,002 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F6 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F7 The option, representing a right to purchase a total of 1,179 shares, becomes exercisable in four equal annual installments beginning on March 8, 2025, which is the first anniversary of the date on which the option was granted.